The Intel Core Ultra 7 CPU Isn't Even a Year Old, but It's Already at a Record Low for Memorial Day Weekend
AAA video games have gotten crazy. The map for Grand Theft Auto 6 set to release next year is approximately two and a half times larger than the explorable area of Grand Theft Auto 5. You can see lights in the environment reflecting off the sweat on characters bodies while they're muscles twist and stretch as they move they way it would for a real person. Whether these result in a game being more 'fun,' is debatable, but what isn't up for discussion is just how much more processing power in needed to play the latest titles in their highest quality. If you haven't upgraded some of your gaming PC parts in awhile, it may be time to replace some stuff.
See at Amazon
Intel refreshes its CPUs on annual basis and the Intel Core Ultra 7 processor came out last year. Since it's release, it's steadily come down in price, but has just now gotten it's biggest drop yet. Originally priced at around $400, it has since been cut down by 33%. That amounts to a savings of $135, marking it down to just $269—it's lowest price ever.
'Do More With Less'
Intel boasts the Intel Core Ultra 7 CPU will improve both performance and efficiency, allowing your PC to run cool, quiet, and fast, delivering up to 5.5GHz. It's contains 20 cores (eight P-cores plus 12 E-cores) along with 20 threads. You'll be able to have better gaming experience while using less power. In other words, 'do more with less.'
Play all the latest big-budget video games with hyper realistic graphics and crazy good frame rates. And if you stream to Twitch or YouTube, you don't want your performance to suffer while taking on the extra task. You want ultra-smooth and responsive gameplay for both you and your viewers to experience, and Intel is here to help.
A solid processor like this isn't just good for gaming. If you find yourself regularly using the Adobe suite of apps, you'll find reliable performance with the Intel Core Ultra 7. Efficiently touch up photos or create massive designs in Photoshop without slowdown, render videos fast when working with Adobe Premiere, and much more.
For better or for worse, AI is becoming is huge demand in the tech space. Intel promises it's Intel Core Ultra processor is ready to take on not just your gaming and streaming.
The Intel Core Ultra 7 processor is designed for legendary gaming experiences but is capable of even more than that. And right now, Amazon reduced it by a third of its price. Order it today for just $269.
See at Amazon
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Can Fundstrat's Tom Lee Make BitMine Immersion Stock the ‘MicroStrategy of Ethereum'?
BitMine Immersion (BMNR) shares soared more than 500% on Monday after the crypto mining firm named Fundstrat's head of research Tom Lee its new chairman of the board. More importantly, the Los Angeles-headquartered company announced plans to raise about $250 million through a private placement, proceeds from which, it confirmed, will be used to buy Ethereum (ETHUSD). Jeff Bezos Unloads $5.4B in Amazon Shares: Should You Buy or Sell AMZN Stock Now? Options Flow Alert: Bulls Making Their Move in GOOGL Stock Is Palantir Stock a Buy, Sell, or Hold on New Nuclear Deal? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Today's rally has inflated BMNR's market cap to well over $150 million. Under Tom Lee as chairman, BitMine plans on using Ether as its primary treasury reserve asset. According to the market veteran, ETH stands to benefit rather significantly now that the U.S. Senate has approved the much-anticipated 'Genius Act.' The legislation clears the path for stablecoins to traverse further into mainstream adoption, which could benefit the world's second-largest crypto since 'Ethereum is the blockchain where the majority of stablecoin payments are transacted,' Lee said in a statement today. Moving forward, the mining company will use ETH held per share as a key performance metric, he added. In short, Lee aims at transforming BitMine Immersion shares into the 'MicroStrategy of Ethereum.' Tom Lee has picked Ethereum as the future reserve asset for BMNR since he remains bullish on what the future holds for the cryptocurrency. According to his forecast from late 2024, ETH should hit $5,000 by the end of this year, indicating potential for a 100% rally over the next six months. However, in the near term, it's reasonable to question whether BitMine Immersion stock will be able to sustain its gains accumulated this morning. Investors should learn from the example of SharpLink (SBET) as well, which announced a similar Ether strategy last month, resulting in an explosive initial rally that all but faded just as quickly in the subsequent sessions. Caution is warranted in chasing the cosmic run in BMNR shares today also because no Wall Street analysts tracked by Barchart currently cover this BTC mining firm, indicating it's not on the radar for institutional investors – at least for now. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
New AI tool is better than doctors at diagnosing complicated medical issues, Microsoft says
Microsoft said it is one step closer to 'medical superintelligence' after a new artificial intelligence (AI) tool beat doctors at diagnosing complex medical problems. Tech giants are racing to develop superintelligence, which refers to an AI system that exceeds human intellectual abilities in every way – and they're promising to use it to upend healthcare systems around the world. For the latest experiment, Microsoft tested an AI diagnostic system against 21 experienced physicians, using real-world case studies from 304 patients that were published in the New England Journal of Medicine, a leading medical journal. The AI tool correctly diagnosed up to 85.5 per cent of cases – roughly four times more than the group of doctors from the United Kingdom and the United States, who had between five and 20 years of experience. Related As AI reshapes patient care, human nurses are pushing back against its creeping influence The model was also cheaper than human doctors, ordering fewer scans and tests to reach the correct diagnosis, the analysis found. Microsoft said the findings indicate that AI models can reason through complex diagnostic problems that stump physicians, who specialise in their fields but are not experts in every aspect of medicine. However, AI 'can blend both breadth and depth of expertise, demonstrating clinical reasoning capabilities that, across many aspects of clinical reasoning, exceed those of any individual physician,' Microsoft executives said in a press release. 'This kind of reasoning has the potential to reshape healthcare'. Microsoft does not see AI replacing doctors anytime soon, saying the tools will instead help physicians automate some routine tasks, personalise patients' treatment, and speed up diagnoses. Microsoft's AI system made diagnoses by mimicking a doctor's process of collecting a patient's details, ordering tests, and eventually narrowing down a medical diagnosis. A 'gatekeeper agent' had information from the patient case studies. It interacted with a 'diagnostic orchestrator' that asked questions and ordered tests, receiving results from the real-world workups. Related Is AI going to steal your job? Probably not, new study finds The company tested the system with leading AI models, including GPT, Llama, Claude, Gemini, Grok, and DeepSeek. OpenAI's o3 model, which is integrated into ChatGPT, correctly solved 85.5 per cent of the patient cases, compared to an average of 20 per cent among the group of 21 experienced doctors. The researchers published their findings online as a preprint article, meaning it has not yet been peer-reviewed. Microsoft also acknowledged some key limitations, notably that the AI tool has only been tested for complicated health problems, not more common, everyday issues. Related AI to shape EU health policymaking without new rules The panel of doctors also worked without access to their colleagues, textbooks, or other tools that they might typically use when making diagnoses. 'This was done to enable a fair comparison to raw human performance,' Microsoft said. The company called for more real-world evidence on AI's potential in health clinics, and said it will 'rigorously test and validate these approaches' before making them more widely available.
Yahoo
34 minutes ago
- Yahoo
Why Intel Growth Story May Be Hitting a Wall
June 26 - Intel (NASDAQ:INTC) could be heading into tougher terrain as geopolitical tensions and new export rules weigh heavily on the chipmaker's China-reliant business. While the company continues to promote its AI and foundry ambitions under new CEO Lip-Bu Tan, its fundamental outlook remains fragile amid a shifting regulatory landscape. Taiwan's recent move to include Huawei and SMIC on its Strategic High-Tech Commodities Entity List marks another potential blow. The change effectively blocks the export of semiconductor products to firms without a special license, disrupting Intel's access to Huawei, a key PC customer in China. Huawei's MateBook lineup, powered by Intel Core Ultra processors, saw growing momentum in 2024, but future deliveries may now face delays or compliance hurdles. Warning! GuruFocus has detected 7 Warning Signs with INTC. Intel's dependence on China, where it derived about 29% of its 2024 revenue, primarily through its Client Computing Group (NASDAQ:CCG), exposes it to tightening U.S. and allied export controls. The CCG unit, which accounted for more than 60% of Intel's consolidated sales in Q1, remains a core earnings driver. But any shift in trade policy that restricts sales of mainstream PC chips, even indirectly, could weigh on results. The chip maker is also dealing with wider execution issues. Its combativeness into AI servers through the Gaudi platform lags behind the shark competitor Nvidia (NASDAQ:NVDA), and the enhanced suspension of Falcon Shores chips highlights execution remnants. Meanwhile, the capital requirements of Intel Foundry are high, and it is not completely clear how the solution will be adopted by external customers long-term. The action by Taiwan in July which evoked this move was an attempt to restrict its exports as part of the U.S attempt to restrict the Chinese access to advanced technologies. All these developments echo previous shocks, including the mid-2024 cancellation of Intel export licenses to Huawei that resulted in 30% plunges when its stock failed to meet results in China. There is relatively no response in the market yet, as Intel shares remained around $20 in spite of such accumulating risks. But analysts caution that this complacency will not be sustained. Having weak underlying principles, poor performance of its AI roadmap, and growing headwinds within the regulatory environment, the Intel stock might be subjected to the continuation of its decline. This article first appeared on GuruFocus. Sign in to access your portfolio
